Long-term rectal administration of high-dose sustained-release morphine tablets

Supportive Care in Cancer

Volumn 10, Issue 8, 2002, Pages 653-655

  Walsh, Declan ^a,b   Tropiano, Pamela S ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cancer pain; Morphine; Opioid conversion; Suppository; Sustained release morphine tablets

Indexed keywords

MORPHINE SULFATE;

AGED; ANALGESIA; ARTICLE; BIOAVAILABILITY; CANCER PAIN; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MEGADOSE; HUMAN; MALE; PRIORITY JOURNAL; SUPPOSITORY; SUSTAINED RELEASE PREPARATION;

ADMINISTRATION, RECTAL; AGED; ANALGESICS, OPIOID; BONE NEOPLASMS; DELAYED-ACTION PREPARATIONS; HUMANS; MALE; MORPHINE; NAUSEA; PAIN; PROSTATIC NEOPLASMS; TABLETS;

EID: 0036933026     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-002-0357-0     Document Type: Article

References (9)

1. Maloney CM, Kesner RK, Klein G, Bockenstette J (1989) The rectal administration of M-S Contin™: clinical implications of use in end stage cancer. Am J Hospice Care 6:34-35
2. Walsh TD, Cheater FM (1983) Use of morphine for cancer pain. Pharm J 10:525-527
3. Walsh TD, Smyth E, Currie C (1992) A pilot study, review of literature, and dosing guidelines for patient-controlled analgesia using subcutaneous morphine sulphate for chronic cancer pain. Palliat Med 6:217-226
4. Garuer PA, Bass J, Wenzel E, et al (1992) A feasibility study of the rectal and vaginal administration of sustained-release morphine sulfate tablets for the treatment of cancer-related pain. Proc Am Soc Clin Oncol 11:1392
5. Kaiko RF, Fitzmartin RD, Thomas GB (1992) The bioavailability of morphine in controlled-release 30 mg tablets per rectum compared with immediate-release 30 mg rectal suppositories and controlled release 30 mg tablets. Pharmacotherapy 12:107-113
6. Babul N, Provencher L, Laberge F, et al (1998) Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain. J Clin Pharmacol 38:74-81
7. Glare PA, Walsh TD (1991) Clinical pharmacokinetics of morphine. Ther Drug Monitor 13:1-23
8. Enck RD (1988) Mucosal membranes as alternative routes for morphine sulfate administration. Am J Hospice Care 5:17-18
9. Davis M, Walsh D, LeGrand S, Naughton M (2002) Symptom control in cancer patients: the clinical pharmacology and therapeutic role of suppositories and rectal suspensions. Support Care Cancer 10:117-138